Clinical Trial Update: A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

The update summarizes the safety and efficacy results of SK-0503 for diabetic macular edema in a phase 1/phase 2 study. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• SK-0503

Snippet

Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd. | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: COMPLETED